American Oncology Network, Inc. AONC
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 28.31% | -2,002.09% | 139.57% | -- | -- |
| Total Depreciation and Amortization | 15.72% | 8.85% | -0.32% | -- | -- |
| Total Amortization of Deferred Charges | -22.62% | 11.77% | 26.50% | -- | -- |
| Total Other Non-Cash Items | 98.62% | -6.11% | -1,265.41% | -- | -- |
| Change in Net Operating Assets | -268.69% | -83.27% | 300.08% | -- | -- |
| Cash from Operations | 72.72% | -97.80% | -597.00% | -- | -- |
| Capital Expenditure | -70.59% | -48.98% | -19.90% | -- | -- |
| Sale of Property, Plant, and Equipment | -69.03% | -11.76% | -59.79% | -- | -- |
| Cash Acquisitions | -- | -134,140.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 204.52% | 282.79% | -1,044.56% | -- | -- |
| Cash from Investing | 93.21% | 115.42% | -260.36% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -694.27% | -637.20% | -457.21% | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -3,974.16% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -100.00% | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.01% | -31.97% | -- | -- |
| Other Financing Activities | -- | -100.79% | 204.93% | -- | -- |
| Cash from Financing | -24.61% | -113.31% | -108.98% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,027.09% | -315.24% | -183.43% | -- | -- |